In this study, we report for the first time the effect rhoifolin on attenuating inflammation in RA by estimating edema, levels of cytokines TNF-α, IL-1β, and IL-6, and the transcription factor NF-κB. The gene discussed is NFKB1; the disease is rheumatoid arthritis.